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The final arrival of the new Manchester book is of
great interest to all of us in clinical oncology. It is
very well produced and printed by Springer, and
the price is standard for a book of this size in 1985.
It shows all the virtues of Ralston Paterson's 1947
and 1963 books and the spirit of "R.P.", the father
figure, can be glimpsed through most of the book,
with further influence, but no radical changes, from
Eric Easson, Robert Gibb and Bob Pointon. The
Manchester philosophy of standard treatment
policies, clearly prescribed initially, continued and
completed whenever possible, without modification,
with vigorous dosage over 1, 8, 15 or 20 daily
fractions, is very much alive. Radium has been
replaced by caesium, but needles rather than
iridium wire are used, and the old insistence on
good planning, done by the doctors themselves, is
unaltered.
The chapters on philosophy and principles by
Eric Easson himself, and on radiobiology by
Malcolm Sutton and Jolyon Hendry give one a
good idea of the background. The "mould room
practice" chapter by Pointon and Dianne Studd is
first class and this and the physics chapter by
Greene and Stephenson alone make the book well
worth buying, though there is much more. There is
a good chapter on chemotherapy by Wilkinson and
Fox which is restrained and sensible, including
sections on etoposide and cis-platinum for example,
but not mentioning the newer analogues or possible
substitutes to cis-platinum and doxorubicin. There
is a chapter and appendices on clinical trials and on
Paterson-Parker mould and implant calculations
and on clinical staging.
The clinical chapters describe exactly what is
done at the Christie. If one follows the treatment
given, one can rely on achieving as good results as
are obtained almost anywhere by radiotherapy,
though sometimes probably with slightly more
severe acute and long-term normal tissue effects.
Derek Crowther comes in to collaborate with Ian
Todd and Peter Wilkinson on lymphoma, a very
good chapter with treatment results and
recommendations for further reading. Gynaeco-
logical cancer - Moya Cole and Robin Hunter - is
well done, with full description of the classical
Manchester technique with insertions in the knee-
chest position, followed by a description of caesium
after loading using the Selectron system. Only
interim recommendations are given for correction
factors to dosage from higher dose-rates. The
breast chapter by Ribeiro is interesting, kilovoltage
therapy is still given for chest wall treatments
though electron treatment is also described.
Hormone treatment with receptor assays is outlined
but chemotherapy is dealt with in the chemo-
therapy chapter. "Adjuvant" chemotherapy is not
advocated and is barely mentioned. The "head and
neck" - Duthie, Gupta and Pointon - now includes
mouth, lip and cervical nodes and is good. Space
does not allow mention of the other tumour sites -
all are well done.
This is essentially, as described, a Manchester
handbook of radiotherapy. Anybody who takes
radiotherapy seriously (and of course this means
everybody!) should read it, there is much to be
gained by Londoners as well as by Americans and
indeed all clinical oncologists. There ought,
however, in the next edition - much sooner please
than twenty years ahead I to be a mention of
results, more references and "further reading",
more discussion of radiotherapy combination with
chemotherapy, and some background comparison
at least with what is done outside Manchester.
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The volumes in this series are usually first class and
this is no exception - its seven articles provide a
veritable goldmine of information and cover a very
wide area.
The first chapter by Byers and Graham reviews
the epidemiology of diet and cancer and
summarises a fascinating spectrum of dietary
factors and their association with different forms of
human cancer. The problems of measuring "diet",
of changes in diet with time and of relating dietary
causal factors to cancers which appear some six to
20 years later are lucidly discussed, as are recent
intervention studies involving changes in diet.
Gordon writes on the molecular aspects of
immunoglobulin expression by human B cell
leukaemias and lymphomas and this is an excellent
far-ranging discussion on B cell malignancies. Our
understanding of B cell systems has undergone a
revolution over recent years due to the development
and use of monoclonal antibodies and recombinant